Cargando…

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery

Background: Ovarian cancer (OC) is the leading cause of death from gynecologic malignancy and is treated with a combination of cytoreductive surgery and platinum-based chemotherapy. Extended length of stay (LOS) after surgery can affect patient morbidity, overall costs, and hospital resource utiliza...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Christopher G., Davenport, Daniel L., Gorski, Justin, McDowell, Anthony, Burgess, Brian T., Fredericks, Tricia I., Baldwin, Lauren A., Miller, Rachel W., DeSimone, Christopher P., Dietrich, Charles S., Gallion, Holly H., Pavlik, Edward J., van Nagell, John R., Ueland, Frederick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787623/
https://www.ncbi.nlm.nih.gov/pubmed/31277282
http://dx.doi.org/10.3390/healthcare7030085
_version_ 1783458307648782336
author Smith, Christopher G.
Davenport, Daniel L.
Gorski, Justin
McDowell, Anthony
Burgess, Brian T.
Fredericks, Tricia I.
Baldwin, Lauren A.
Miller, Rachel W.
DeSimone, Christopher P.
Dietrich, Charles S.
Gallion, Holly H.
Pavlik, Edward J.
van Nagell, John R.
Ueland, Frederick R.
author_facet Smith, Christopher G.
Davenport, Daniel L.
Gorski, Justin
McDowell, Anthony
Burgess, Brian T.
Fredericks, Tricia I.
Baldwin, Lauren A.
Miller, Rachel W.
DeSimone, Christopher P.
Dietrich, Charles S.
Gallion, Holly H.
Pavlik, Edward J.
van Nagell, John R.
Ueland, Frederick R.
author_sort Smith, Christopher G.
collection PubMed
description Background: Ovarian cancer (OC) is the leading cause of death from gynecologic malignancy and is treated with a combination of cytoreductive surgery and platinum-based chemotherapy. Extended length of stay (LOS) after surgery can affect patient morbidity, overall costs, and hospital resource utilization. The primary objective of this study was to identify factors contributing to prolonged LOS for women undergoing surgery for ovarian cancer. Methods: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was queried to identify women from 2012–2016 who underwent hysterectomy for ovarian, fallopian tube and peritoneal cancer. The primary outcome was LOS >50th percentile. Preoperative and intraoperative variables were examined to determine which were associated with prolonged LOS. Results: From 2012–2016, 1771 women underwent elective abdominal surgery for OC and were entered in the ACS-NSQIP database. The mean and median LOS was 4.6 and 4.0 days (IQR 0–38), respectively. On multivariate analysis, factors associated with prolonged LOS included: American Society of Anesthesiologists (ASA) Classification III (aOR 1.71, 95% CI 1.38–2.13) or IV (aOR 1.88, 95% CI 1.44–2.46), presence of ascites (aOR 1.88, 95% CI 1.44–2.46), older age (aOR 1.23, 95% CI 1.13–1.35), platelet count >400,000/mm(3) (aOR 1.74, 95% CI 1.29–2.35), preoperative blood transfusion (aOR 11.00, 95% CI 1.28–94.77), disseminated cancer (aOR 1.28, 95% CI 1.03–1.60), increased length of operation (121–180 min, aOR 1.47, 95% CI 1.13-1.91; >180 min, aOR 2.78, 95% CI 2.13–3.64), and postoperative blood transfusion within 72 h of incision (aOR 2.04, 95% CI 1.59–2.62) (p < 0.05 for all). Conclusions: Longer length of hospital stay following surgery for OC is associated with many patient, disease, and treatment-related factors. The extent of surgery, as evidenced by perioperative blood transfusion and length of surgical procedure, is a factor that can potentially be modified to shorten LOS, improve patient outcomes, and reduce hospital costs.
format Online
Article
Text
id pubmed-6787623
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67876232019-10-16 Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery Smith, Christopher G. Davenport, Daniel L. Gorski, Justin McDowell, Anthony Burgess, Brian T. Fredericks, Tricia I. Baldwin, Lauren A. Miller, Rachel W. DeSimone, Christopher P. Dietrich, Charles S. Gallion, Holly H. Pavlik, Edward J. van Nagell, John R. Ueland, Frederick R. Healthcare (Basel) Article Background: Ovarian cancer (OC) is the leading cause of death from gynecologic malignancy and is treated with a combination of cytoreductive surgery and platinum-based chemotherapy. Extended length of stay (LOS) after surgery can affect patient morbidity, overall costs, and hospital resource utilization. The primary objective of this study was to identify factors contributing to prolonged LOS for women undergoing surgery for ovarian cancer. Methods: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was queried to identify women from 2012–2016 who underwent hysterectomy for ovarian, fallopian tube and peritoneal cancer. The primary outcome was LOS >50th percentile. Preoperative and intraoperative variables were examined to determine which were associated with prolonged LOS. Results: From 2012–2016, 1771 women underwent elective abdominal surgery for OC and were entered in the ACS-NSQIP database. The mean and median LOS was 4.6 and 4.0 days (IQR 0–38), respectively. On multivariate analysis, factors associated with prolonged LOS included: American Society of Anesthesiologists (ASA) Classification III (aOR 1.71, 95% CI 1.38–2.13) or IV (aOR 1.88, 95% CI 1.44–2.46), presence of ascites (aOR 1.88, 95% CI 1.44–2.46), older age (aOR 1.23, 95% CI 1.13–1.35), platelet count >400,000/mm(3) (aOR 1.74, 95% CI 1.29–2.35), preoperative blood transfusion (aOR 11.00, 95% CI 1.28–94.77), disseminated cancer (aOR 1.28, 95% CI 1.03–1.60), increased length of operation (121–180 min, aOR 1.47, 95% CI 1.13-1.91; >180 min, aOR 2.78, 95% CI 2.13–3.64), and postoperative blood transfusion within 72 h of incision (aOR 2.04, 95% CI 1.59–2.62) (p < 0.05 for all). Conclusions: Longer length of hospital stay following surgery for OC is associated with many patient, disease, and treatment-related factors. The extent of surgery, as evidenced by perioperative blood transfusion and length of surgical procedure, is a factor that can potentially be modified to shorten LOS, improve patient outcomes, and reduce hospital costs. MDPI 2019-07-03 /pmc/articles/PMC6787623/ /pubmed/31277282 http://dx.doi.org/10.3390/healthcare7030085 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Smith, Christopher G.
Davenport, Daniel L.
Gorski, Justin
McDowell, Anthony
Burgess, Brian T.
Fredericks, Tricia I.
Baldwin, Lauren A.
Miller, Rachel W.
DeSimone, Christopher P.
Dietrich, Charles S.
Gallion, Holly H.
Pavlik, Edward J.
van Nagell, John R.
Ueland, Frederick R.
Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title_full Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title_fullStr Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title_full_unstemmed Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title_short Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
title_sort clinical factors associated with longer hospital stay following ovarian cancer surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787623/
https://www.ncbi.nlm.nih.gov/pubmed/31277282
http://dx.doi.org/10.3390/healthcare7030085
work_keys_str_mv AT smithchristopherg clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT davenportdaniell clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT gorskijustin clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT mcdowellanthony clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT burgessbriant clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT frederickstriciai clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT baldwinlaurena clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT millerrachelw clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT desimonechristopherp clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT dietrichcharless clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT gallionhollyh clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT pavlikedwardj clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT vannagelljohnr clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery
AT uelandfrederickr clinicalfactorsassociatedwithlongerhospitalstayfollowingovariancancersurgery